Cytek Biosciences (Nasdaq: CTKB) sets severance and consulting terms
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Cytek Biosciences, Inc. set out separation arrangements for former Chief Legal Officer and Corporate Secretary Valerie Barnett, whose position ended on June 29, 2026. On July 9, 2026, the parties entered into a Severance Agreement including a one-time lump-sum payment of $365,775.12 and payment of COBRA premiums through the earlier of April 30, 2027, or the date she becomes covered under another employer’s group health plan.
If a Change in Control occurs within three months after the Separation Date, Ms. Barnett instead becomes eligible for change-in-control severance equal to 18 months of base salary plus her 2026 bonus target, with the previously paid severance credited, extended COBRA coverage through January 31, 2028, and full vesting of outstanding equity awards. The company also entered into a Consulting Agreement effective July 10, 2026, under which she will provide transition support at $1,000 per hour, up to 10 hours per week, through August 31, 2026, with continued vesting of existing equity awards during her service.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
1 item
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Key Figures
Severance payment: $365,775.12
COBRA coverage period: through April 30, 2027
Change in Control window: three (3) months
+5 more
8 metrics
Severance payment
$365,775.12
One-time lump sum severance owed to Ms. Barnett under the Severance Agreement
COBRA coverage period
through April 30, 2027
COBRA premiums paid until this date or earlier coverage under another employer plan
Change in Control window
three (3) months
Period after July 9, 2026 Separation Date for enhanced severance eligibility
Change in Control salary multiple
eighteen (18) months
Base salary period paid if a Change in Control occurs within the protection window
COBRA with Change in Control
through January 31, 2028
COBRA premiums paid if Change in Control severance applies
Consulting hourly rate
$1,000 per hour
Rate for transition support services under the Consulting Agreement
Consulting weekly cap
ten (10) hours per week
Maximum number of consulting hours Ms. Barnett may provide each week
Consulting term end date
August 31, 2026
Initial term end date of the Consulting Agreement
Key Terms
COBRA premiums, Change in Control, Severance Agreement, Consulting Agreement, +1 more
5 terms
Change in Control financial
"In the event the Company experiences a Change in Control within three (3) months"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
Severance Agreement financial
"entered into a severance agreement and release of all claims (the “Severance Agreement”)"
Consulting Agreement financial
"The Company and Ms. Barnett also entered into a Consulting Agreement effective July 10, 2026"
Continuous Service financial
"will continue to vest, subject to her Continuous Service (as defined in the Plan)"
FAQ
What severance will Valerie Barnett receive from Cytek Biosciences (CTKB)?
Valerie Barnett will receive a $365,775.12 lump-sum severance payment and COBRA premiums paid until the earlier of April 30, 2027, or coverage under another employer’s group health plan, in exchange for providing a release and waiver of claims.
What happens under the CTKB agreements if a Change in Control occurs?
If a Change in Control occurs within three months after July 9, 2026, Ms. Barnett becomes eligible for severance equal to 18 months of base salary plus her 2026 bonus target, COBRA premiums through January 31, 2028, and full vesting of all then-outstanding equity awards.
What are the main terms of Valerie Barnett’s consulting agreement with Cytek Biosciences (CTKB)?
The Consulting Agreement is effective July 10, 2026. Ms. Barnett will provide transition support at $1,000 per hour, for up to 10 hours per week, with an initial term running through August 31, 2026, subject to early termination or extension by mutual written agreement.
How long does the Change in Control protection period last for Valerie Barnett at CTKB?
The Change in Control protection applies for three (3) months following the July 9, 2026 Separation Date. A qualifying Change in Control during this period triggers the enhanced cash severance, extended COBRA coverage and accelerated vesting of Ms. Barnett’s then-outstanding equity awards.
What is the treatment of Valerie Barnett’s equity awards under the Cytek Biosciences (CTKB) arrangements?
While the Consulting Agreement is in effect, Ms. Barnett’s existing equity awards under the 2021 Equity Incentive Plan will continue to vest, subject to her Continuous Service. If a Change in Control occurs within the protection period, all then-outstanding equity awards become fully vested and exercisable.